NEO

NeoGenomics, Inc. (NEO) Financial Statements

Review NeoGenomics, Inc. (NEO) financials with server-rendered company data, supporting context and links to related investor research.

Annual revenue
$727.33M
Annual gross profit
$314.29M
Annual operating income
$-88.13M
Annual net income
$-108.03M
Annual free cash flow
$-21.78M
Total assets
$1.36B
Total liabilities
$523.27M
Shareholder equity
$836.56M

NeoGenomics, Inc. (NEO) Financial Statements research

The NeoGenomics, Inc. financials page brings together the latest available annual and trailing figures for revenue, profitability, cash generation and balance-sheet strength. Comparing these measures across reporting periods can reveal whether operating performance and financial resilience are improving or weakening.

Revenue and earnings should be assessed together with free cash flow, assets, liabilities and debt ratios. A single figure is not a complete investment thesis, so use the linked analysis and valuation pages to place the reported results in context.